| Tag | Content |
|---|
EnhancerAtlas ID | HS141-01319 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr1:161699820-161700690 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr1:161699848-161699863 | TGAACTCCTGACCTC | - | 6.22 | | TBX21 | MA0690.1 | chr1:161700095-161700105 | TTCACACCTT | - | 6.02 | | TBX2 | MA0688.1 | chr1:161700094-161700105 | ATTCACACCTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_56629 | chr1:161698532-161702049 | u87 | | SE_58760 | chr1:161674084-161711741 | Ly1 | | SE_59497 | chr1:161674276-161714796 | Ly3 | | SE_61570 | chr1:161674449-161712145 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161729 | chr1 | 161699268 | 161701012 |
|
Enhancer Sequence | GGTTTCACCG TGTTGGCCAG GCTGGTCTTG AACTCCTGAC CTCAGGTGAT CCACCTGCCT 60
CAGCCTCCCA AAGTGCAGGG ATTACAGGCT TGGGCCACCG CGCCCGGCCG GTTTCTGCCA 120
TCTTGATATA GACAGGAAGT GACTAACATT AGTGGCAAGA GGCTTAGTAA TCAAAGAATC 180
TCAGGTCATT TAAAAAATCA GTTGATCATT TTTTAAGAGT ACAAAAAAGA GAAATAGTTA 240
CTCAAAGGAG AGCTAGGGCA GCAGTATCTC TTTCATTCAC ACCTTTTTGG CAACATCAAC 300
ATCCTTGTTC TTGTTTTGCC ATCTACTTCC ATTTAGAACT AGGATGCGGG GGGATGGGGA 360
AGAACAAGGA CTTTTTGGTG AGAGTGAAAA TCATTCATGA CTCAACTTTC TGGTGTAGGG 420
GAGAGGAATT GACTCATATG GCCTGTAGAC TCCACTGTCT TCTTCGTGTA CCCCAGCTTT 480
TAAGAGGAGG GCAGGATCAA GATGATCTTC TAAGATATCT GTTATTGATC TCCCAGGAAG 540
ACCTGCATTA AGGAAATATC AGCTTCATCT TCATCCCTTT TGTTTGAGGT TCCTACATGC 600
ATTTAGGGAA ACCAGAAGGC TAGCTAGCCC AGGTTGTCCA AGGGGACTCT CAGAGCTCAT 660
TCCCAAACAG CAGGGATGGC AGAAAAATGC TGGAGAAACC TAGGGAGGAA TCTGCTTCTC 720
TCTGATACTC TGATCAGTTT GGTGTCTCAG ACTTAGGCTG CAAACCCTAA TCCTGCGGCT 780
GTCCATAGCA GATGCCAGAC AAGGAACCCC AATGTCCGCT ATCAGAGAGC AGAAAAAATT 840
CTGTCGCATT CCCTTTGGAT TTCAGCCTTA 870
|
